Physostigmine antagonizes ketamine-induced noradrenaline release from the medial prefrontal cortex in rats

Brain Res. 1999 Sep 4;840(1-2):175-8. doi: 10.1016/s0006-8993(99)01793-x.

Abstract

Physostigmine is known to antagonize ketamine anesthesia. In this study, effects of physostigmine (0.1 mg kg(-1) i.p.) on ketamine (100 mg kg(-1) i.p.)-induced anesthesia time and noradrenaline release from the medial prefrontal cortex in rats were examined. Ketamine produced anesthesia for 27+/-1 min and increased noradrenaline release to 405% of the basal. Physostigmine significantly reduced anesthesia time to 23+/-1 min (p<0.05), and noradrenaline to 248% (p<0.05). Therefore, noradrenaline release may play an important role in ketamine anesthesia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anesthesia
  • Anesthetics, Dissociative / pharmacology*
  • Animals
  • Cholinesterase Inhibitors / pharmacology*
  • Ketamine / pharmacology*
  • Male
  • Norepinephrine / antagonists & inhibitors*
  • Norepinephrine / metabolism
  • Physostigmine / pharmacology*
  • Prefrontal Cortex / drug effects*
  • Prefrontal Cortex / metabolism*
  • Rats
  • Rats, Wistar
  • Time Factors

Substances

  • Anesthetics, Dissociative
  • Cholinesterase Inhibitors
  • Ketamine
  • Physostigmine
  • Norepinephrine